Keros Therapeutics, Inc. (KROS)

11.78 +0.01 (+0.08%) USD  |  NASDAQ  |  May 06, 16:00
11.82 +0.04 (+0.34%) After-Hours: 20:00
More

Keros Therapeutics Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for KROS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Sarepta Therapeutics, Inc. Upgrade
PTC Therapeutics, Inc. Upgrade
Insmed, Inc. Upgrade
United Therapeutics Corp. Upgrade
Opus Genetics, Inc. Upgrade